The New Yorker @NewYorker
Researchers began studying ketamine as a treatment for depression, and, in 2006, the National Institute of Mental Health concluded that a single intravenous dose of ketamine had rapid antidepressant effects. https://t.co/mgZ4bpcnYs — PolitiTweet.org